ClinicalTrials.gg
Not yet recruitingNCT06765525Updated Jan 9, 2025

Efficacy Study of DeepDDH System in Screening Infants with Developmental Dysplasia of the Hip (DDH)

An interventional study of Junior sonographer measurement of DDH and Senior sonographer measurement of DDH in Hip Dysplasia, Developmental, sponsored by RenJi Hospital. Not yet recruiting at 1 site in China. Open to participants aged 28 Days to 6 Months. Per ClinicalTrials.gov, last updated 2025-01-09.

Sponsored by RenJi Hospital · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,976
Allocation
Randomized
Ages
28 Days to 6 Months
Sex
All
01

Study summary

To ascertain the efficacy of the DeepDDH system, a deep learning framework, in enhancing diagnostic accuracy and curtailing follow-up intervals for infants undergoing screening for developmental dysplasia of the hip (DDH), the researchers are executing a blinded, randomized controlled trial. This trial juxtaposes AI-only and AI-assisted assessments of DDH against sonographer interpretations across various proficiency levels in the preliminary analysis of ultrasound images.

Read the detailed description
  1. Participating centers and doctors:

    The data in the ultrasound screening sequence database in this part of the study were mainly from Renji Hospital, Shanghai Jiao Tong University School of Medicine and the Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine. Renji Hospital, the Sixth People's Hospita, and the Pediatric Hospital Affiliated to Fudan University, three top-three hospitals in Shanghai, started Graf ultrasound examination earlier, with an average history of more than 10 years. Each unit can perform Graf ultrasound examination maturely, and has good quality control and management. The technology is relatively mature, and they are responsible for providing 6 expert sonographers with more than 5-10 years of DDH ultrasound diagnosis experience, more than 600 DDH ultrasound operations, and 1 pediatric orthopedic expert with 5-10 years of DDH diagnosis experience to participate in the study. However, several other primary or remote medical institutions with late DDH ultrasound screening and insufficient diagnostic experience were mainly responsible for providing 8 primary sonographers (trained residents who performed 20 DDH ultrasound operations) to participate in the study. The other 4 primary sonographers who participated in the study were provided by the Sixth People's Hospital and the Pediatric Hospital Affiliated to Fudan University, so a total of 12 primary sonographers participated in the study. Before the study, the sonographers involved in this study will be evaluated uniformly and quantitatively through online examination papers.

  2. Research process:

One week before the start of the randomized diagnostic trial study, which prospectively reevaluated the retrospective data set of the ultrasound screening sequence database, the sonographers registered in the study received uniform training in the latest DDH ultrasound diagnosis in the form of PPT, video, literature study, and offline instruction.

For the included cases in the ultrasound screening sequence database, they would appear in different control groups in a random form, such as the AI model, the Expert sonographer group (composed of 6 ultrasound experts), the primary sonographer group (composed of 6 primary sonographers), and the primary sonographer (composed of 6 primary sonographers) + AI-assisted group. All the image data in the ultrasound screening sequence database were independently divided into measurement points and measurement lines by each group, and the final diagnosis of α Angle, β Angle and classification results were given by the system.

The random occurrence of cases in the ultrasound screening sequence database has certain rules: (1) According to the date of ultrasound examination, the 2152 ultrasound screenings were divided into 848 days. (2) Block randomization was applied to the 848-day study, using a computer-generated sequence of random numbers, with randomization performed in blocks of four or eight. That is, the cases examined for the first time in each day were divided into one group (AI group, advanced ultrasound expert group, primary sonographer group, AI-assisted primary sonographer group), and the cases for follow-up examination were divided according to the first examination group. Randomization was repeated within each group according to block randomization of 6 or 12 block sizes.

When non-first subsequent follow-up cases were randomly presented, the results of the previous examination were included as a reference. In the AI-assisted group, each sonographer was asked to choose whether to modify or confirm the diagnosis according to the measurement points, diagnostic angles and typing results provided by the AI device. However, in the advanced ultrasound expert group, junior sonographer unassisted group, the dedicated research assistant will turn off the AI display function to ensure that no additional information is provided to the sonographer. The consensus of two ultrasound experts with 10 years of experience in DDH ultrasound diagnosis was used as the gold standard. In case of disagreement, a third pediatric expert with 5-10 years of experience in DDH diagnosis and treatment was used to evaluate the diagnosis and treatment of DDH. The final consensus was used as the gold standard.

Finally, the operation results of the above different groups were summarized and analyzed by independent research assistants, including α Angle, β Angle, typing results, and the specific follow-up experience of the case (including follow-up times and follow-up time).

02

Conditions studied

  • Hip Dysplasia, Developmental
03

In context

Developmental Dysplasia of the Hip

60 studies on the registry are indexed under Developmental Dysplasia of the Hip; 18 are open to participants now.

This study's planned enrollment of 1,976 is above the median of 59 across 38 interventional studies indexed under Developmental Dysplasia of the Hip.

Browse Developmental Dysplasia of the Hip studies →

Lead sponsor

RenJi Hospital is the lead sponsor of 550 studies on the registry; 247 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
28 Days to 6 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants aged 28 days to 6 months who underwent DDH ultrasound examination in Renji Hospital, Shanghai Jiaotong University School of Medicine and the Sixth People's Hospital, Shanghai Jiaotong University School of Medicine between August 2014 and December 2021

Exclusion criteria

Exclusion Criteria:

  • Patients lacking or incomplete ultrasound images;
  • Patients with poor image quality and unusable images after assessment, including non-compliance with Anatomical identification (Checklist I consists of seven anatomical structures: 1. Chondro-osseous border, 2. Femoral head, 3. Synovial fold, 4. Joint capsule and perichondrium, 5. Labrum, 6. Cartilagineous roof, 7. Bony roof) and Usability check (Checklist II includes three anatomical landmarks: 1. Lower limb of the os ilium, 2. Parallel middle plane, and 3. Labrum);
  • Infants with hip dysplasia caused by other diseases such as cerebral palsy, joint contracture, suppurative coxitis, etc., or with other hip diseases and limb deformities.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
1,976 participants (estimated)

Study arms

  • Active comparator
    Junior Sonographer Annotation

    Participants will not receive visual cues from the DeepDDH system. Junior sonographer technicians will offer preliminary interpretations before these are subjected to validation and subsequent review by expert's team.

    Other: Junior sonographer measurement of DDH

  • Active comparator
    Senior Sonographer Annotation

    Participants will not receive visual cues from the DeepDDH system.

    Other: Senior sonographer measurement of DDH

  • Experimental
    DeepDDH system Annotation

    Through randomization, a subset of the preliminary interpretations will be conducted by AI technology, and the study team will evaluate the degree of divergence between these AI-generated preliminary interpretations and the final interpretations.

    Other: Automated annotation of the DDH measurement through deep learning

  • Experimental
    DeepDDH-assist Junior Sonographer Annotation

    Participants will receive visual cues from the DeepDDH system.

    Other: AI-assisted junior sonographer meaturement of DDH

Interventions

  • OtherJunior sonographer measurement of DDH

    Participants will not receive visual cues from the DeepDDH system. Junior sonographer technicians will offer preliminary interpretations before these are subjected to validation and subsequent review by expert's team.

    Also known as: Junior Sonographer Annotation

  • OtherSenior sonographer measurement of DDH

    Participants will not receive visual cues from the DeepDDH system.

    Also known as: Senior Sonographer Annotation

  • OtherAutomated annotation of the DDH measurement through deep learning

    Through randomization, a subset of the preliminary interpretations will be conducted by AI technology, and the study team will evaluate the degree of divergence between these AI-generated preliminary interpretations and the final interpretations.

    Also known as: DeepDDH system Annotation

  • OtherAI-assisted junior sonographer meaturement of DDH

    Participants will receive visual cues from the DeepDDH system.

    Also known as: DeepDDH-assist Junior Sonographer Annotation

06

What researchers measure

Primary outcomes

  1. Average diagnostic accuracy

    It is calculated by dividing the number of preliminary interpretations that are consistent with the expert team's grading by the total number of cases that should be diagnosed.

    Time frame: 30 Minutes

Secondary outcomes

  1. Average diagnostic sensitivity

    It is calculated by dividing the number of true positive cases by the sum of true positive cases and false negative cases.

    Time frame: 30 Minutes

  2. Average diagnostic specificity

    It is calculated by dividing the number of true negative cases by the sum of true negative cases and false positive cases.

    Time frame: 30 Minutes

  3. Average times of follow-up visits

    The average number of follow-up visits for each group is obtained by dividing the total number of follow-up visits for each participating infant within the group by the number of participating infants in that group. The specific calculation of follow-up visits is as follows: For each participating infant, if a false positive diagnosis is made and there are no more subsequent follow-up examination results, the number of follow-up visits is increased by 1; if a false negative diagnosis leads to the end of the follow-up process for the participating infant, then no further follow-up visits are counted.

    Time frame: 30 Minutes

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The clinical demographic information of the subjects was recorded through the Case Record Form, and the data was collected and managed electronically through the ResMan platform.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2025; primary completion for Mar 2025, 2 months later.

Of 20 interventional studies with no phase under Developmental Dysplasia of the Hip, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 3, 2025
First posted
Jan 9, 2025
StartEst.
Jan 15, 2025
Primary completionEst.
Mar 30, 2025
CompletionEst.
Apr 30, 2025
Last update
Jan 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06765525
Lead sponsor
RenJi Hospital
Responsible party
Lixin Jiang (Director of Department of ultrasound in medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, RenJi Hospital) — Principal investigator
First posted
Jan 9, 2025
Start date
Jan 15, 2025 (estimated)
Primary completion
Mar 30, 2025 (estimated)
Completion
Apr 30, 2025 (estimated)
Last update
Jan 9, 2025

Study contacts

Lixin Jiang, PhD
Contact
jinger_28@sina.com
+86 18930173496
Mengyao Liu, PhD
Contact
mengyao_liu08@163.com
+86 17521618149

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion